Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220020952 220009142 1.62 78.4 null 2017-12-13 2017-12-13 IPO N N 220034434 CYCLOPHOSPHAMIDE HIGH DOSE
220020953 220009154 null 35.8 Curative (C) 2017-05-29 2017-08-04 NHL 2003 Gp C M1 N N 220034482 PEMBROLIZUMAB
220020954 220009161 null 67.5 Curative (C) 2015-02-11 2015-02-25 Cytarabine+Methotrexate Intrathecal N N 220034495 METHOTREXATE + PEGASPARGASE
220020955 220009169 1.71 44.8 null 2019-09-28 2019-09-28 Arsenic Triox + Tretinoin Ind W1-4 N N 220034510 VINORELBINE
220020956 220009185 1.72 66.5 Palliative (P) 2016-07-12 2016-07-12 ALL UKALL60+ TRIAL 2 N 220034571 CLOFARABINE + DAUNORUBICIN
220020957 220009195 1.6 44.4 Curative (C) 2016-07-19 2016-07-20 AML LI-1 Trial 2 N 220034611 MACE
220020958 220014898 1.59 20.9 Curative (C) 2018-08-23 2018-08-23 Pemetrexed 02 N 220034662 CETUXIMAB
220020959 220009207 1.61 64.6 Curative (C) 2014-01-06 2014-03-29 CISPLATIN + ETOPOSIDE 1 N 220034670 BUSULFAN + CYCLOPHOSPHAMIDE
220020960 220009214 null null Curative (C) 2017-02-27 2017-10-27 ETOPOSIDE null N 220034678 CISPLATIN + FLUOROURACIL
220020961 220009219 1.69 79.9 Curative (C) 2016-08-26 2016-09-15 BENDAMUSTINE + RITUXIMAB 01 null 220034690 PERTUZUMAB + TRASTUZUMAB
220020962 220009224 1.76 66.5 Curative (C) 2013-07-13 2014-01-27 CETUXIMAB 2 N 220034697 ARSENIC TRIOXIDE + ATRA
220020963 220009240 1.5 115.4 Curative (C) 2014-12-13 2014-12-25 CYTARABINE + FLUDARABINE N N 220034796 MA
220020964 220009250 0 87 Curative (C) 2016-03-05 2016-03-05 ALL UKALL60+ TRIAL 02 N 220034834 INTERFERON
220020965 220018143 null 75 Curative (C) 2017-05-16 2017-05-16 FIGARO TRIAL null null 220034845 UKALL60+
220020966 220009266 1.64 62.7 Curative (C) 2015-08-01 2015-08-02 Alemtuzumab + Cyclophos TBI Allo N Y 220034935 UKALL2011
220020967 220009279 1.3 45 Disease modification (D) 2016-12-27 2017-01-04 Bevacizumab+Carbo+Pacliaxel N null 220035065 BUSULFAN + FLUDARABINE
220020970 220021011 1.64 88.65 Palliative (P) 2015-03-11 2015-04-14 Ifosfamide N N 220035113 DABRAFENIB + TRAMETINIB
220020971 220009302 1.72 53 Curative (C) 2016-12-23 2017-07-14 GCLAC 2 N 220035146 UKALL 2003
220020972 220009314 1.72 72.3 Curative (C) 2018-07-01 2018-07-07 CETUXIMAB N null 220035189 BORTEZOMIB + THALIDOMIDE
220020973 220009326 1.95 111 Disease modification (D) 2019-03-17 2019-03-23 Doxorubin 50mg/m2 02 N 220035229 BUSULPHAN
220020974 220018160 1.58 62.899 Curative (C) 2017-12-27 2018-01-15 ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE + MELPHALAN null null 220035232 METHOTREXATE + PEGASPARGASE
220020975 220009341 1.64 53 Curative (C) 2015-04-08 2015-05-01 FIGARO TRIAL N N 220035299 ARSENIC TRIOXIDE + ATRA
220020976 220009346 1.72 83.7 null 2015-04-19 2015-04-19 Cetuximab + FOLFIRI cycle 2 onwards N N 220035329 ALEMTUZUMAB + CYCLO + FLUDARABINE
220020977 220009348 null 83.2 Disease modification (D) 2014-02-09 2014-02-09 ATG + Busulfan + Fludarabine + Thiotepa N N 220035332 CYTARABINE + FLUDARABINE + IDARUBICIN
220020978 220009352 1.54 64 Palliative (P) 2013-05-11 2013-05-12 INTERFERON N N 220035347 CETUXIMAB + CISPLATIN + FU
220020979 220009360 null 77 Curative (C) 2018-03-27 2018-03-27 Gemcitabine weekly N N 220035373 PEMBROLIZUMAB
220020980 220009364 1.7 null Curative (C) 2018-01-13 2018-01-16 FLUDARABINE null null 220035392 CYTARABINE IT + METHOTREXATE
220020981 220009368 1.7 61.9 Disease modification (D) 2017-07-05 2017-07-11 VINORELBINE 02 null 220035406 VIOLA TRIAL
220020982 220009372 null 103.75 Palliative (P) 2016-04-14 2016-04-15 ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE + MELPHALAN N N 220035412 BEP
220020983 220009378 1.9 0 Curative (C) 2014-04-21 2014-04-22 PEMBROLIZUMAB N N 220035414 MA
220020984 220009381 1.68 null Curative (C) 2019-01-03 2019-02-13 Bevacizumab 5mg/kg 02 N 220035428 GEMCITABINE
220020986 220009393 1.81 80.3 Curative (C) 2014-05-16 2014-06-27 FIGARO TRIAL 02 N 220035488 CAPECITABINE + OXALIPLATIN
220020987 220009398 1.75 65 Curative (C) 2014-04-21 2014-05-08 ALEMTUZUMAB + FLUDARABINE 2 N 220035497 QUASAR 2 TRIAL
220020988 220009401 null null null 2017-01-06 2017-01-06 Spanish Maintenance (Months 4-24) null N 220035535 CLOFARABINE + DAUNORUBICIN
220020990 220018180 null 17.1 Curative (C) 2015-05-27 2015-07-06 Etoposide oral 02 N 220035549 BENDAMUSTINE + RITUXIMAB
220020991 220009413 null 67 Palliative (P) 2018-01-06 2018-01-10 NHL 2003 Gp C M1 N null 220035566 CYTARABINE IT + METHOTREXATE
220020992 220009424 null null Palliative (P) 2014-08-29 2014-08-29 PAD N N 220035632 EOX
220020993 220009427 0 50.3 Curative (C) 2016-05-06 2016-08-15 BUSULFAN + FLUDARABINE + METHOTREXATE 02 N 220035638 TRASTUZUMAB
220020994 220015002 1.62 76 Disease modification (D) 2015-08-09 2015-08-09 MidAC N N 220035672 MACE
220020995 220009439 null 86 Curative (C) 2017-10-11 2017-10-11 ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE + MELPHALAN Y null 220035742 ARSENIC TRIOXIDE
220020997 220015008 1.49 58.8 Disease modification (D) 2018-05-11 2018-05-19 ALEMTUZUMAB + FLUDARABINE 02 N 220035765 ROMAZA TRIAL
220020998 220015024 1.82 23.7 null 2014-12-03 2015-01-11 Venetoclax 02 N 220035925 CYTARABINE + FLUDARABINE + IDARUBICIN
220020999 220018197 1.62 102.4 Adjuvant (A) null 2014-03-25 Mercaptopurine 02 N 220035943 INTERFERON
220021000 220009475 null 66.95 Curative (C) 2017-08-06 2017-08-09 Cetuximab 7 day (>Cycle 2) N N 220035947 BORTEZOMIB
220021001 220009489 null null null 2014-07-20 2014-07-22 BENDAMUSTINE + RITUXIMAB N null 220036013 PEMBROLIZUMAB
220021002 220015036 1.69 61.7 Curative (C) 2015-03-17 2015-03-17 Bevacizumab 5mg/kg 2 N 220036034 EVEROLIMUS
220021003 220009498 1.63 87.2 Curative (C) 2017-01-21 2017-01-24 Etoposide oral 2 N 220036060 CAPECITABINE + CARBOPLATIN
220021004 220009500 null 11.4 Curative (C) 2015-12-28 2016-03-16 FIGARO TRIAL 02 N 220036062 BUSULPHAN + CYCLO
220021005 220009510 1.8 null Curative (C) 2015-12-01 2015-12-03 ALL UKALL60+ TRIAL N N 220036121 LIPOSOMAL CYTARABINE
220021007 220009527 1.77 84.5 Palliative (P) null 2016-03-24 TRASTUZUMAB N N 220036202 IPILIMUMAB